Penn Medicine Head and Neck Cancer Service Line COVID-19 management guidelines.

Authors :: Weinstein GS
Cohen R
Lin A
O'Malley BW Jr
Lukens J
Swisher-McClure S
Shanti RM
Newman JG
Parhar HS
Tasche K
Brody RM
Chalian A
Cannady S
Palmer JN
Adappa ND
Kohanski MA
Bauml J
Aggarwal C
Montone K
Livolsi V
Baloch ZW
Jalaly JB
Cooper K
Rajasekaran K
Loevner L
Rassekh C
Source :: Head & neck [Head Neck] 2020 Jul; Vol. 42 (7), pp. 1507-1515. Date of Electronic Publication: 2020 Jun 25.
Publication Year :: 2020
Abstract: Introduction: The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus has altered the health care environment for the management of head and neck cancers. The purpose of these guidelines is to provide direction during the pandemic for rational Head and Neck Cancer management in order to achieve a medically and ethically appropriate balance of risks and benefits.<br />Methods: Creation of consensus document.<br />Results: The process yielded a consensus statement among a wide range of practitioners involved in the management of patients with head and neck cancer in a multihospital tertiary care health system.<br />Conclusions: These guidelines support an ethical approach for the management of head and neck cancers during the COVID-19 epidemic consistent with both the local standard of care as well as the head and neck oncological literature.<br /> (© 2020 Wiley Periodicals, Inc.)